Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-002110
Filing Date
2017-03-29
Accepted
2017-03-29 07:42:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2231549z424b5.htm 424B5 446249
2 G90680.JPG g90680.jpg GRAPHIC 30502
  Complete submission text file 0001047469-17-002110.txt   489362
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-216573 | Film No.: 17720661
SIC: 2834 Pharmaceutical Preparations